Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) is now available.
SMS Pharmaceuticals Limited has announced that it has complied with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending December 31, 2024. This compliance highlights the company’s adherence to regulatory standards, which is crucial for maintaining its market credibility and ensuring seamless operations for stakeholders.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited operates within the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is known for its commitment to quality and compliance, catering to both domestic and international markets.
YTD Price Performance: -13.89%
Average Trading Volume: 17,054
Current Market Cap: 18.81B INR
See more data about SMSPHARMA stock on TipRanks’ Stock Analysis page.